UN Warns DRC Ebola Outbreak Has Killed 2,500 as Funds Near Exhaustion Within Weeks
Updated
Updated · The Guardian · Aug 22
UN Warns DRC Ebola Outbreak Has Killed 2,500 as Funds Near Exhaustion Within Weeks
3 articles · Updated · The Guardian · Aug 22
Summary
More than 2,500 people have died in the Democratic Republic of the Congo's Ebola outbreak, and the UN says infections are now spreading faster and wider than the response.
Julien Harneis said current funding will run out within weeks, while 160 health workers have been infected and 43 have died as the virus expands across an area larger than France.
Unpaid frontline staff are adding strain to the response: workers in Bunia said they are missing wages or bonuses even as confirmed cases keep arriving and some colleagues have died.
Misinformation, mistrust and weak infrastructure are also driving transmission, with suspected patients avoiding treatment centres, hiding in communities and helping create new clusters.
The WHO says the Bundibugyo-strain outbreak could surpass West Africa's 2014-16 epidemic as the world's largest ever; it has spread to six DRC provinces, with no approved vaccine or treatment.
With no vaccine and funding running dry, can frontline workers stop the rare Ebola strain before it escapes the conflict-ridden Congo?
Why are burned ambulances and a failing banking system proving to be just as lethal as the Ebola virus itself?
The 2026 Bundibugyo Ebola Outbreak: Unprecedented Spread, Root Causes, and the Global Response Crisis
Overview
The August 2026 Bundibugyo Ebola outbreak spread rapidly across the Democratic Republic of the Congo and into Uganda, fueled by violent conflict that displaced over 100,000 people and made contact tracing nearly impossible. Severe food insecurity and malnutrition weakened millions, increasing vulnerability to Ebola and forcing families to break isolation or migrate in search of food, which drove further transmission. Funding shortfalls forced humanitarian agencies to cut food aid, worsening hunger and disease spread. With no approved vaccine or treatment for the Bundibugyo strain, containment relied on traditional measures, while new vaccine trials began only after promising animal data. The crisis exposed the urgent need for resilient health systems and sustained investment in preparedness.